Anavex Life Sciences Corp.
Nasdaq AVXL · New York, NY
Works in Genetic & rare · Neurology · Psychiatry
Anavex Life Sciences Corp. is a clinical trial sponsor based in New York, NY, listed as Nasdaq AVXL. It has 1 active clinical trial with 71 planned participants, in Genetic & rare, Neurology and Psychiatry. Since 2021 it has completed 8 trials and stopped 0 early.
Trial track record · since 2021
Financials · Nasdaq AVXL
Pipeline · 1 active trial
| Stage | Trial | Status |
|---|---|---|
Questions about Anavex Life Sciences Corp
Anavex Life Sciences Corp is lead sponsor of 1 active clinical trial on ClinicalTrials.gov, with 71 planned participants, in Genetic & rare, Neurology, Psychiatry. Since 2021 it has completed 8 trials and stopped 0 early.
Anavex Life Sciences Corp is based in New York, NY and is listed as Nasdaq AVXL. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Anavex Life Sciences Corp; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2025-05-04.
Approve Suite is not affiliated with Anavex Life Sciences Corp..
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.